Ruschitzka F - Search Results

1

FastTrack: a key success factor for the European Heart Journal.

Lüscher TF, Gersh B, Hindricks G, Landmesser U, Ruschitzka F, Wijns W. Lüscher TF, et al. Among authors: ruschitzka f. Eur Heart J. 2014 Aug 7;35(30):1983-90. Eur Heart J. 2014. PMID: 25254272 No abstract available.

2

Endothelin: culprit or bystander in Addison's disease?

Ruschitzka FT, Lüscher TF. Ruschitzka FT, et al. Eur J Endocrinol. 1996 Dec;135(6):645-8. doi: 10.1530/eje.0.1350645. Eur J Endocrinol. 1996. PMID: 9025703 No abstract available.

3

Is there a rationale for combining angiotensin-converting enzyme inhibitors and calcium antagonists in cardiovascular disease?

Ruschitzka FT, Lüscher TF. Ruschitzka FT, et al. Am Heart J. 1997 Aug;134(2 Pt 2):S31-47. doi: 10.1016/s0002-8703(97)70007-3. Am Heart J. 1997. PMID: 9313622 Review.

4

The endothelium in coronary artery disease.

Ruschitzka FT, Noll G, Lüscher TF. Ruschitzka FT, et al. Cardiology. 1997;88 Suppl 3:3-19. doi: 10.1159/000177500. Cardiology. 1997. PMID: 9397288 Review.

5

Combination of ACE inhibitors and calcium antagonists: a logical approach.

Ruschitzka FT, Noll G, Lüscher TF. Ruschitzka FT, et al. J Cardiovasc Pharmacol. 1998;31 Suppl 2:S5-16. doi: 10.1097/00005344-199800002-00002. J Cardiovasc Pharmacol. 1998. PMID: 9605596 Review.

6

[Calcium antagonists. Results of recent studies and their significance for general practice].

Ruschitzka FT, Noll G, Lüscher TF. Ruschitzka FT, et al. Internist (Berl). 1999 Feb;40(2):225-34. doi: 10.1007/s001080050327. Internist (Berl). 1999. PMID: 10097989 Review. German. No abstract available.

7

Angiotensin converting enzyme inhibitors and vascular protection in hypertension.

Ruschitzka F, Noll G, Lüscher TF. Ruschitzka F, et al. J Cardiovasc Pharmacol. 1999 Aug;34 Suppl 1:S3-12. doi: 10.1097/00005344-199908001-00002. J Cardiovasc Pharmacol. 1999. PMID: 10499558 Review.

8

Endothelin receptor antagonists in congestive heart failure: a new therapeutic principle for the future?

Spieker LE, Noll G, Ruschitzka FT, Lüscher TF. Spieker LE, et al. Among authors: ruschitzka ft. J Am Coll Cardiol. 2001 May;37(6):1493-505. doi: 10.1016/s0735-1097(01)01210-4. J Am Coll Cardiol. 2001. PMID: 11345356 Free article. Review.

9

Endothelin A receptor antagonists in congestive heart failure: blocking the beast while leaving the beauty untouched?

Spieker LE, Noll G, Ruschitzka FT, Lüscher TF. Spieker LE, et al. Among authors: ruschitzka ft. Heart Fail Rev. 2001 Dec;6(4):301-15. doi: 10.1023/a:1011456309039. Heart Fail Rev. 2001. PMID: 11447305 Review.

10

Vasopeptidase inhibition: effective blood pressure control for vascular protection.

Quaschning T, Ruschitzka F, Lüscher TF. Quaschning T, et al. Among authors: ruschitzka f. Curr Hypertens Rep. 2002 Feb;4(1):78-84. doi: 10.1007/s11906-002-0057-7. Curr Hypertens Rep. 2002. PMID: 11790296 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

607 results

Search Page

Filters